The company, which currently operates an Illumina MiniSeq, has found social media to be a useful tool for generating leads.
The funding will help the company to grow its business, which brokers sequencing service deals through a global online system.
The services will couple NEB's reagents and expertise in enzyme development and manufacturing with TTP's Desktop Biology product development and engineering know-how.
The British molecular diagnostics company plans to make its array-based test for early-stage Alzheimer's disease available in the US by year end.
BGI will start offering quantitative RNA-seq services on the BGISEQ-500 soon, followed by whole-genome sequencing later this year.
N-of-One will interpret data from HemeSeq profiles for acute myeloid leukemia, chronic lymphocytic leukemia, diffuse large B-cell lymphoma, and other cancers.
The newly minted company offers panel, whole-genome and whole exome sequencing, as well as bioinformatics analysis and reporting services to oncologists.
GeneWiz will implement multiple Dragen processors to reduce turnaround times for its genomic data analysis services business.
The firm is launching a service that will enable researchers to incorporate genetics into studies and incentivize participation with a 23andMe account.
The company intends to provide no-cost subscriptions to the Cloudera platform for storage, processing, and analyzing big data to researchers at some 50 institutions.
The ancestors of the Arizona bark scorpion and other scorpions and spiders underwent whole-genome duplication, KJZZ reports.
A cryptographic approach could help researchers keep genomic data private while researchers analyze it, Scientific American reports.
Andy Page, the former president of 23andMe, has joined a diabetes-management startup, according to CNBC.
In Cell this week: regulatory changes in pancreatic cancer, metabolic shifts in Alzheimer's disease, and more.